In Episode 53 of Bladder Cancer Matters, host Rick Bangs talks with Dr. Tom Powles about an interesting clinical trial he and others conducted studying the effectiveness of a drug to treat metastatic bladder cancer. Among other topics, they discuss: 

• The JAVELIN 100 trial that successfully studied the effectiveness of avelumab after chemotherapy in bladder cancer patients who have locally advanced metastatic disease
• What avelumab is and how it is used
• The questions that Dr. Powles hoped would be answered by the JAVELIN 100 trial
• How those conducting the trial assessed the quality of life of the patients receiving avelumab
• The role that wearable technology like a smartwatch can play in measuring patients’ quality of life and health 

Never miss an episode of Bladder Cancer Matters by subscribing in your favorite podcasting platform.